Strategic Fund Product Prices: Anti-Malarial Medicines (valid until 31-Dec-2020)

Strategic Fund Product Prices: Anti-Malarial Medicines

Long Term Agreement valid until 31 December 2020

Notes:

1. The prices published reflect the price of the product

2. For budgeting purposes PAHO suggests Member States add an additional 15-25% to reflect the costs of shipping, insurance, 3% contribution to the SF capital account and the 1.25% PAHO fee.

3. Medicines not included in this list, can be purchase individually upon request by Member States. Prices and lead-time will depend on the product availability at the time of the request.

4. Questions should be directed to strategicfund@paho.org

 

Download (138.01 KB)